で公開中です! 詳しく見る
MLYSのアイコン

Mineralys Therapeutics

名前 保有額 取引額 株数
増減
保有比率の
変化
CP
1
Catalys Pacific
Japan
$2.13億 – – –
RA Capital Management
2
RA Capital Management
Massachusetts
$2.08億 – – –
BlackRock
3
BlackRock
New York
$1.59億 +$3856万 +1,405,456 +31%
Samsara BioCapital
4
Samsara BioCapital
California
$1.58億 – – –
Fidelity Investments
5
Fidelity Investments
Massachusetts
$1.22億 -$959万 -349,415 -7%
State Street
6
State Street
Massachusetts
$1.12億 +$3308万 +1,205,696 +41%
Deerfield Management
7
Deerfield Management
New York
$1.07億 +$1.09億 +3,958,000 新規
Vanguard Capital Management
8
Vanguard Capital Management
Pennsylvania
$7438万 +$830万 +302,407 +12%
Laurion Capital Management
9
Laurion Capital Management
New York
$6762万 +$752万 +274,112 +12%
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$6104万 +$2522万 +919,163 +68%
OrbiMed
11
OrbiMed
New York
$5694万 +$157万 +57,400 +3%
Capital World Investors
12
Capital World Investors
California
$5390万 +$4388万 +1,599,428 +402%
Armistice Capital
13
Armistice Capital
New York
$4684万 +$1536万 +560,000 +48%
Troluce Capital Advisors
14
Troluce Capital Advisors
Puerto Rico
$4664万 +$2946万 +1,073,753 +164%
Franklin Resources
15
Franklin Resources
California
$4413万 -$409万 -149,142 -8%
AP
16
Andera Partners
$4295万 – – –
Geode Capital Management
17
Geode Capital Management
Massachusetts
$4275万 +$777万 +283,191 +22%
SR One Capital Management
18
SR One Capital Management
Pennsylvania
$4220万 – – –
Bank of America
19
Bank of America
North Carolina
$4062万 +$1112万 +405,175 +37%
Sphera Funds Management
20
Sphera Funds Management
Israel
$3966万 +$357万 +130,000 +10%
Goldman Sachs
21
Goldman Sachs
New York
$3936万 +$1848万 +673,633 +86%
Pictet Asset Management
22
Pictet Asset Management
Switzerland
$3860万 +$1087万 +396,211 +38%
Polar Capital Holdings
23
Polar Capital Holdings
United Kingdom
$3833万 -$219万 -79,895 -5%
Millennium Management
24
Millennium Management
New York
$3296万 +$1911万 +696,498 +133%
Ghisallo Capital Management
25
Ghisallo Capital Management
Massachusetts
$3035万 +$3087万 +1,125,000 新規